Nationwide Cross-sectional Analysis of Endoscopic Thoracic Sympathectomy to Treat Hyperhidrosis Over 12 years in Brazil Epidemiology, Costs, and Mortality
Carregando...
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
LOUZADA, Andressa Cristina Sposato
SILVA, Marcelo Fiorelli Alexandrino da
PORTUGAL, Maria Fernanda Cassino
TEIVELIS, Marcelo Passos
JERUSSALMY, Claudia Szlejf
AMARO, Edson
Citação
ANNALS OF SURGERY, v.277, n.2, p.E483-E487, 2023
Resumo
Objective:To analyze the number of endoscopic thoracic sympathectomies performed to treat hyperhidrosis in the Universal Public Health System of Brazil, the government reimbursements, and the in-hospital mortality rates. Background:Even though endoscopic thoracic sympathectomy has been widely performed for the definitive treatment of hyperhidrosis, no series reported mortality and there are no population-based studies evaluating its costs or its mortality rate. Methods:Data referring to endoscopic thoracic sympathectomy to treat hyperhidrosis between 2008 and 2019 were extracted from the database of the Brazilian Public Health System, which insures more than 160 million inhabitants. Results:Thirteen thousand two hundred one endoscopic thoracic sympathectomies to treat hyperhidrosis were performed from 2008 to 2019, with a rate of 68.44 procedures per 10 million inhabitants per year. There were 6 in-hospital deaths during the whole period, representing a mortality rate of 0.045%. The total expended throughout the years was U$ 6,767,825.14, with an average of U$ 512.68 per patient. Conclusions:We observed a rate of 68.44 thoracoscopic sympathectomies for hyperhidrosis' treatment per 10 million inhabitants per year. The inhospital mortality rate was very low, 0.045%, though not nil. To our knowledge, no published series is larger than ours and we are the first authors to formally report deaths after endoscopic thoracic sympathectomies to treat hyperhidrosis. Moreover, there is no other population-based study addressing costs and mortality rates of every endoscopic thoracic sympathectomy for the treatment of any site of hyperhidrosis in a given period.
Palavras-chave
big data, endoscopic thoracic surgery, hyperhidrosis, public health, sympathectomy, vascular diseases
Referências
- Cerfolio RJ, 2011, ANN THORAC SURG, V91, P1642, DOI 10.1016/j.athoracsur.2011.01.105
- Chen JF, 2019, SURGERY, V166, P1092, DOI 10.1016/j.surg.2019.05.039
- Chu DC, 2010, KAOHSIUNG J MED SCI, V26, P123, DOI 10.1016/S1607-551X(10)70018-8
- de Moura NB, 2013, ANN THORAC SURG, V95, P465, DOI 10.1016/j.athoracsur.2012.10.068
- Doolittle J, 2016, ARCH DERMATOL RES, V308, P743, DOI 10.1007/s00403-016-1697-9
- DROTT C, 1995, J AM ACAD DERMATOL, V33, P78, DOI 10.1016/0190-9622(95)90015-2
- Estevan FA, 2017, AN BRAS DERMATOL, V92, P629, DOI 10.1590/abd1806-4841.20175551
- Faustino CB, 2020, ANN VASC SURG, V65, P107, DOI 10.1016/j.avsg.2019.04.024
- Fujimoto T, 2013, J DERMATOL, V40, P886, DOI 10.1111/1346-8138.12258
- Gossot D, 2001, ANN THORAC SURG, V71, P1116, DOI 10.1016/S0003-4975(01)02422-5
- Isla-Tejera B, 2013, DERMATOLOGY THER, V3, P63, DOI 10.1007/s13555-013-0025-y
- Kuijpers M, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-216
- Lembranca L, 2017, ANN VASC SURG, V43, P283, DOI 10.1016/j.avsg.2017.01.018
- Lin TS, 1999, SURG NEUROL, V52, P453, DOI 10.1016/S0090-3019(99)00111-1
- de Campos JRM, 2016, THORAC SURG CLIN, V26, P435, DOI 10.1016/j.thorsurg.2016.06.008
- Ministry of Health of Brazil, US
- Nicolini Eveline Montessi, 2019, Rev Col Bras Cir, V46, pe2157, DOI 10.1590/0100-6991e-20192157
- Ojimba TA, 2004, BRIT J SURG, V91, P264, DOI 10.1002/bjs.4511
- Shayesteh A, 2016, DERMATOLOGY, V232, P586, DOI 10.1159/000448032
- Shelley WB, 1998, J AM ACAD DERMATOL, V38, P227, DOI 10.1016/S0190-9622(98)70242-7
- Strutton DR, 2004, J AM ACAD DERMATOL, V51, P241, DOI 10.1016/j.jaad.2003.12.040
- United Nations Development Programme Fundacao Joao Pinheiro Instituto de Pesquisa Economica Aplicada, 2016, PRIMEIRA EDICAO
- Universal public health system (SUS) of Brazil, AUT INT HOSP APR
- Wolosker N, 2020, INT J DERMATOL, V59, P709, DOI 10.1111/ijd.14872
- Wolosker N, 2015, PEDIATR DERMATOL, V32, P663, DOI 10.1111/pde.12385
- Wolosker N, 2014, CLIN AUTON RES, V24, P297, DOI 10.1007/s10286-014-0264-8
- Wolosker N, 2014, AN BRAS DERMATOL, V89, P912
- Wolosker N, 2014, ANN VASC SURG, V28, P1106, DOI 10.1016/j.avsg.2013.12.024
- Wolosker N, 2013, REV ASSOC MED BRAS, V59, P143, DOI 10.1016/j.ramb.2012.11.002
- Wolosker N, 2012, EINSTEIN-SAO PAULO, V10, P405, DOI 10.1590/S1679-45082012000400002
- Wolosker N, 2012, J VASC SURG, V55, P1696, DOI 10.1016/j.jvs.2011.12.039
- Wolosker N, 2010, CLINICS, V65, P583
- Wolosker N, 2010, J VASC SURG, V51, P1190, DOI 10.1016/j.jvs.2009.11.078